All posts tagged
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
What do the CAR-T Patient Deaths Mean for the Future of the Field?
UniQure’s cure for rare Lysosomal disease ready for phase III trial
German Viral Vector Producer SIRION pursues its American dream and opens in Boston
GSK sparks off the Gene Therapy resurgence
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Forbion Capital Partners: a Leading European Biotech VC is rising!
The First Gene Therapy Drug Will Be Sold at Record €1,1M Price
Should European Biotech CEOs wear more sneakers?
Labiotech UG, All Rights Reserved -
Send this to a friend